AYTU

AYTU BioPharma, Inc. Common Stock

2.28

USD

-0.03

-1.30%

Sep 25, 15:59 UTC -4

Closed

After-Market

2.27

-0.01

-0.66%

AYTU BioPharma, Inc. Common Stock Profile

About

Aytu BioPharma Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system diseases to improve the quality of life for patients. Aytu BioPharma Inc., formerly known as AYTU BIOSCIENCE, is based in DENVER, CO.

Info & Links

CEO

Joshua R. Disbrow

Headquarters

7900 E. UNION AVENUE, SUITE 920
DENVER, CO 80237, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

183

Employees

AYTU BioPharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

24.31M

Enterprise Value

19.41M

Enterprise Value/EBITDA(ttm)

-1.80

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.44

Price to Book(mrq)

0.70

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

63.87%

Operating Margin(ttm)

-26.46%

Profit Margin(ttm)

-25.25%

Return on Equity(ttm)

-56.54%

Return on Invested Capital(ttm)

-50.50%

Return on Assets(ttm)

-13.14%

Income Statement

Revenue(ttm)

56.60M

Revenue Per Share(ttm)

5.27

Gross Profit(ttm)

36.66M

EBITDA(ttm)³

-10.78M

Net Income Available to Common(ttm)

-34.05M

Diluted EPS(ttm)

-1.66

Share Statistics

Beta (5Y Monthly)

0.26

52-Week Change

10.68%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

10.73M

Dividend Yield

0.00%

Float⁴

10.21M

% Held by Insiders

4.90%

% Held by Institutions

33.49%

Balance Sheet

Total Cash(mrq)

26.71M

Total Cash Per Share(mrq)

2.49

Total Debt(mrq)

21.82M

Total Debt/Equity(mrq)

48.28%

Current Ratio(mrq)

1.13%

Quick Ratio(mrq)

1.00%

Book Value Per Share(mrq)

3.29

Cash Flow

Operating Cash Flow Per Share(ytd)

0.27

Free Cash Flow(ytd)

3.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.